Abstract Ethylene glycol (EG), propylene glycol (PG), and diethylene glycol (DEG) are widely used as components of antifreeze liquids for automobiles and in many other products. They occasionally cause severe poisonings when they are ingested in high doses. In this study, we established a detailed procedure for highly sensitive and simultaneous determination of EG, PG, and DEG in human whole blood by isotope dilution gas chromatography-mass spectrometry (GC-MS). A 0.25-ml aliquot of whole blood containing the glycols was mixed with 100 ng each of deuterated EG, PG, and DEG as internal standards. After centrifugation, the supernatant fraction was evaporated to dryness, derivatized with heptafluorobutyric anhydride, and the derivative was extracted with n-hexane; 1 ll of the n-hexane layer was subjected to GC-MS analysis. Contrary to our expectation, appreciable amounts of EG, PG, and DEG were found, even in human whole blood samples obtained from nonoccupational healthy subjects. Because such results have never been reported, in the early stages of this study, we suspected that our results were caused by carry-over of the glycols during the GC-MS procedure; thus, we cleaned the injection port, installed a new GC column, and washed the ion-source chamber. Despite these efforts, the clear peaks were detected at the same retention times as those of the authentic glycols for the extracts of healthy subjects, which led us to confirm the presence of the glycols in the blood of healthy subjects. Because the blank whole blood samples from healthy subjects already contained glycols, we constructed a standard addition calibration curve for each sample; the horizontal intercept point, where the straight calibration line intersected the horizontal concentration axis, showed the background concentration of the glycol. The calibration curves showed linearity in the range of 0.4-400 ng/ml for EG and DEG, and in the range of 4-2,000 ng/ml for PG, with correlation coefficients larger than 0.99. The limits of detection and limits of quantitation could not be exactly determined, because of the unavailability of blank human whole blood without each glycol. However, the values were estimated to be around or lower than 1 ng/ml from the signal-to-noise ratios of peaks for each glycol at the lowest concentrations obtained by selected ion monitoring. To validate the method, intraday and interday repeatability was tested; the percent relative standard deviations were 2.5-12.2 % and 0.8-8.5 %, respectively. Recoveries of the three glycols using whole blood samples of two subjects obtained by a unique method were 61.6-80.9 %. The concentration ranges (mean) of EG, PG, and DEG in whole blood obtained from ten subjects were 39. 1-97.0 (64.0), 49.1-689 (181), and 8.08-22.9 (11.1) ng/ml, respectively. To test the effect of oral intake of PG, two volunteers ingested 100 ml of a commercially available energy drink containing 33.7 mg of PG, the safety of which was accredited by the Japanese Government. The PG levels in the blood of the two subjects increased by 74.0 and 158 % at 1 and 0.5 h, respectively, suggesting that the glycols present in human blood are largely derived from food. To our knowledge, the analytical method for the glycols presented in this article is the most sensitive among those so far reported. In addition, this is the first description of the presence of the glycols in healthy human subjects, which should be useful for setting cutoff levels of the glycols in poisoning cases.
Introduction
Ethylene glycol (EG) is a relatively nonvolatile liquid used as the main component of automotive antifreeze solutions. Propylene glycol (PG) is widely used as a substitute for EG in automotive antifreeze. Because of the low toxicity of PG, it is also used as a preservative, emollient, and vehicle for both oral and intravenous medication in the field of pharmacy. Diethylene glycol (DEG) is also used in automotive antifreeze solutions; it is widely used in industry as a lubricant and solvent. Among the three glycols, DEG is the most toxic followed by EG and PG [1] . Over the past several decades, mass poisonings by DEG have occurred [2] ; it was usually ingested as an unintended component of pharmaceutical preparations. About 600 people worldwide are deemed to have died as a result of DEG poisoning from 1937 to 2006 [2] . Massive ingestion of EG occasionally results in fatal poisoning through severe acidosis and calcium oxalate precipitation in the kidney causing renal failure and death [3] . Although ingestion of large amounts of PG causes seizures, decreased levels of consciousness, and lactic acidosis, there have been no reports of deaths due to poisonings by PG alone [1, 4] .
For analyses of EG, PG, and/or DEG, gas chromatography [5, 6] , gas chromatography-mass spectrometry (GC-MS) [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , liquid chromatography-mass spectrometry (LC-MS) [17, 18] , and liquid chromatography-tandem mass spectrometry [19] have been employed. Perfluorooctanoyl [7] , t-butyldimethylsilyl [10] , pivalylated [11] , methyl [15] , and trimethylsilyl [12, 13, 16] derivatizations of the glycols in human samples were performed prior to analysis by GC-MS. However, all of the above GC-MS methods showed very low sensitivities; even for the newest reports published in 2010 and 2011 [15, 16] , the limit of detection (LOD) and limit of quantitation (LOQ) were as high as 10 and 50 lg/ml, respectively.
In this study, we have developed a much more sensitive method for GC-MS analysis of EG, PG, and DEG in human whole blood, and have found that appreciable amounts of the three glycols exist in whole blood samples of nonoccupational healthy subjects.
Materials and methods

Materials
EG, PG, DEG, EG-d 6 , and PG-d 8 were purchased from Sigma-Aldrich (St. Louis, MO, USA); DEG-d 8 from Cambridge Isotope Laboratories (Andover, MA, USA); heptafluorobutyric (HFB) anhydride from Thermo Fisher Scientific (Waltham, MA, USA). Other common chemicals used were of the highest purity commercially available.
Sep-Pak AC2 Plus short cartridges were purchased from Waters (Milford, MA, USA); ENVI-Carb Plus cartridges from Sigma-Aldrich. Energy drinks tested were: Lipovitan Gold (50 ml) from Taisho Pharmaceutical (Tokyo, Japan); S. Cup (100 ml) from SSP (Tokyo, Japan); New Guromont (100 ml) from Lion (Tokyo, Japan); Herusan Guts (100 ml) from Zeria Pharmaceutical (Tokyo, Japan).
Human experiments
This study including human experiments was approved by the Regional Institutional Board of Hamamatsu University School of Medicine. About 10 ml of blood was sampled from each of five healthy male volunteers (28-47 years of age) and five healthy female volunteers (27-68 years of age) with informed consent. The samples were used immediately or stored frozen until used.
Two healthy male volunteers (both medical doctors, 66 and 30 years old) participated in a simple experiment. Before taking an energy drink containing PG, about 10 ml each of whole blood was sampled from them. Then whole blood samples were collected 0.5, 1.0, and 2.0 h after consuming the drink. The samples were immediately analyzed or stored frozen until analysis.
Extraction procedure A 0.25-ml aliquot of whole blood was mixed with 100 ng each of EG-d 6 , PG-d 8 , and DEG-d 8 dissolved in 10 ll of acetonitrile as internal standards (ISs). To the mixture, 0.75 ml of acetonitrile was added, vortexed, sonicated for 5 min, and centrifuged at 10,000 rpm for 5 min for both extraction and deproteinization. The supernatant fraction was transferred to a 4-ml screw-cap vial, and evaporated to dryness under a stream of nitrogen. To each vial, 100 ll of acetonitrile and 50 ll of HFB anhydride were added; each vial was tightly capped, gently vortexed, and heated at 60°C for 30 min. After cooling and opening the vial, 0.5 ml of Milli-Q water and 0.5 ml of n-hexane were added; the vial was capped and vortexed well for 1 min. The n-hexane layer was transferred to a small test tube containing 0.2 g of anhydrous sodium sulfate, and vortexed for dehydration. After adding 0.5 ml of n-hexane, followed by gentle vortexing, the mixture was allowed to settle; a 1-ll aliquot of the clear n-hexane layer was injected into the GC-MS instrument.
GC-MS conditions
The instrument for GC-MS analysis was GC-2010/GCMS-QP2010 Plus (Shimadzu, Kyoto, Japan) equipped with an AOC-20i autoinjector and an AOC-20s autosampler (both Shimadzu). GC conditions were: column, DB-1 
Results and discussion
Optimization of analytical conditions and preliminary results
For simultaneous analysis of EG, PG, and DEG, various extraction methods were tested. The target compounds were hydrophilic, of low molecular weight, neutral, aliphatic, and thus generally not suitable for solid-phase extraction (SPE). However, we have tried SPE cartridges, such as Sep-Pak AC2 Plus and ENVI-Carb Plus containing activated carbon, for simultaneous extraction using the authentic solution of the glycols. The subsequent recovery rates of EG, PG, and DEG were 7.0, 7.7, and 53 % for the Sep-Pak AC2 Plus cartridge, and 4.0, 8.8, and 86 % for the ENVI-Carb Plus cartridge, respectively. Therefore, we did not persist with the SPE cartridges for simultaneous extraction of the three glycols.
Various derivatizations of glycols were employed in previous reports [7, 10-13, 15, 16] , but their sensitivities obtained by GC-MS were surprisingly low (LODs: 0.12-10 lg/ml). As an alternative, we used HFB anhydride, which is frequently used for derivatization of compounds containing an amino and/or hydroxyl group [20] . We found that HFB derivatives of the glycols gave much higher sensitivity; their LODs were estimated to be around or less than 1 ng/ml. In addition, HFB derivatives are known to be much more stable than trifluoroacetic derivatives, and can be extracted as bis-HFB-glycols by n-hexane in the presence of water. We noticed that the derivatized EG, PG, and DEG were detected from the whole blood samples obtained from untreated and healthy subjects by our sensitive GC-MS method. In the early stages of this research project, we suspected that such a phenomenon was due to carry-over or contamination by previous injections of authentic glycols. We cleaned the injection port, and replaced the GC column with a new column. We also cleaned the ion source chamber of the MS instrument. However, despite these efforts, distinct peaks were detected in mass chromatographic and SIM chromatograms obtained from whole blood extracts of healthy subjects. In addition, because there was a possibility that nondeuterated glycols were included in the deuterated ISs, 100 ng of each of the three ISs was analyzed for the three glycols. However, the ISs showed insignificant peak intensities due to glycols in the SIM chromatograms.
Mass spectra and selected ion monitoring chromatograms
The mass spectra of the authentic glycols and their deuterated compounds after derivatization with HFB anhydride are shown in Fig. 1 . For EG, PG, and their deuterated compounds, the fragments at m/z 169 appeared as the base peaks, which were due to the heptafluoropropyl moiety. For DEG and its deuterated compound, the fragments at m/z 241 and 245 appeared as the base peaks, which were due to the heptafluorobutyrated ethylene moiety. Because all target glycols have two hydroxyl groups, the molecular weights of the derivatized EG, PG, and DEG were 454, 468, and 498, respectively. However, there were no peaks appearing over m/z 275. Therefore, we chose the peaks at m/z 241 and 245 as quantifier ions for the target glycols and their deuterated compounds (ISs), respectively. Fig. 3 An example of selected ion monitoring chromatograms for the three glycols and their spiked deuterated compounds (ISs) for an extract of whole blood of a healthy subject after HFB derivatization Figure 2 shows mass spectra obtained from the whole blood extract of a healthy subject after derivatization. The spectrum obtained at 5.30 min from the sample extract (Fig. 2) was identical with that of the authentic EG (Fig. 1) . For PG, the profile of peaks at m/z 169, 197, 213, 241, and 255 appearing in the mass spectrum of the extract (Fig. 2) was very similar to that of authentic PG (Fig. 1) , but extra peaks at m/z 100, 119, 150, and 226 appeared, showing some impurities coexisted with PG. However, it appeared that use of the peak at m/z 241 as the quantifier peak gave specific measurements of PG in whole blood. For DEG, only a small extra peak appeared at m/z 267 in the mass spectrum of the blood extract (Fig. 2) .
Based on the above results, it was concluded that EG, PG, and DEG do exist in whole blood of healthy subjects. To our knowledge, this is the first report describing the presence of the glycols in body fluids of healthy subjects. This is probably due to the extremely low sensitivities of the previous methods so far reported [7, 10-13, 15, 16] . Figure 3 shows SIM chromatograms for the extract of a whole blood Fig. 4 An example of standard addition calibration curves for the three glycols for a whole blood extract of a healthy subject after HFB derivatization. The intercept point, where the straight calibration curve intersects with the horizontal axis of glycol concentration, reflects the preexisting concentration of a glycol in whole blood. Each calibration curve was constructed with seven plot points at different concentrations 
Calibration curves
Because no blood samples were free from glycol compounds, we had to use a so-called standard addition method for each glycol, as shown in Fig. 4 using each deuterated IS. Because of the preexistence of all glycols, the calibration lines did not pass through the origin, but intersected the vertical and horizontal axes. On each plot, the point of intersection on the horizontal concentration axis gave the the concentration of a glycol in whole blood, albeit as a negative concentration. Therefore, the concentration range of each glycol to be added was adjusted to include a preexisting concentration of the same compound. The preferred plots for determination of a preexisting glycol are shown in the middle panel of Fig. 4 . In this calibration curve, the concentration of PG was 360 ng/ml; the seven plot points ranged from 0.4 to 400 ng/ml. It is clear that the middle panel gave a more accurate determination result than the top or bottom panels.
To confirm the linearity of calibration curves for the three glycols, the standard addition calibration curves were again constructed in the ranges of 0.4-400 ng/ml for EG and DEG, and 4-2,000 ng/ml for PG. Good linearity was observed for all compounds with correlation coefficients greater than 0.99 (Table 1) .
Validation of the method
Because all blood samples contained various concentrations of the glycols, it was impossible to present the usual accuracy and precision data using blank whole blood samples spiked with different concentrations of the authentic glycols (quality controls). Instead, we collected 20 ml each of whole blood from two healthy volunteers, and made intraday and interday measurements for the three glycols using the standard addition calibration curves. The results are shown in Table 2 . The relative standard deviations of the intraday and interday repeatability were 0.8-12.2 %.
The calculation of the recovery rates could not be performed by the conventional method, also because of the preexistence of the glycols in human whole blood. The experiments were, therefore, performed as follows. The whole blood samples were collected from two volunteers, and EG, PG, and DEG concentrations in whole blood samples of two subjects were measured using the standard addition calibration curves. For example, the concentration of EG in whole blood of subject 1 was 165 ng/ml (Table 3) ; the EG amount present in 0.25 ml whole blood was 41.3 ng. This amount was freshly prepared by properly diluting the stock acetonitrile solution of the authentic EG, and the acetonitrile solution was evaporated to dryness, followed by the derivatization and extraction with n-hexane prior to GC-MS analysis. Then, the percent peak area ratio of the whole blood extract to the authentic EG was calculated to give the recovery rate of EG from whole blood. The same procedure was followed for the other glycols in blood samples obtained from the two subjects. The results are shown in Table 3 ; the recovery rates were 61.6-80.9 %, which were generally satisfactory for quantitative analysis.
Concentrations of the glycols in human whole blood and water samples Table 4 shows concentrations of the glycols in whole blood samples obtained from ten volunteers and in three kinds of water samples. The concentration ranges (mean) of EG, PG, and DEG in whole blood were 39.1-97.0 (64.0), 49.1-689 (181), and 8.08-22.9 (11.1) ng/ml, respectively. EG concentrations in water samples were similar to those in human whole blood; PG concentrations in the water samples were much lower than those in the blood samples. DEG concentrations in the water samples were higher than in the blood samples. Effect energy drink on propylene glycol concentrations in whole blood
Because of the low toxicity of PG, it is found in various foods and drinks as a preservative and/or vehicle for various chemicals. Many energy drinks contain various amounts of PG. Four brands of energy drink were obtained, and their PG contents were measured by our method. The PG contents were: 3.63 mg in 50 ml of Lipovitan Gold; 33.7 mg in 100 ml of S.Cup; 1.31 mg in 100 ml of New Guromont; 0.06 mg in 100 ml of Herusen Guts. Therefore, we chose S.Cup energy drink containing 33.7 mg of PG per bottle for human experiments. Two volunteers participated in the experiments, and after consumption of a 100-ml S.Cup energy drink, 10-ml blood samples were collected into sampling tubes containing an anticoagulant at 0.5, 1.0, and 2.0 h. The results are shown in Table 5 . For one subject, the PG concentration increased from 473 to 823 ng/ml (increase by 74.0 %) at 1.0 h; the level was still significantly higher than the initial level at 2.0 h. For the other subject, the PG concentration increased from 161 to 415 ng/ml (increase by 158 %) at 0.5 h, and the level at 2.0 h was much higher than the initial level. The above experimental results support the idea that the glycols present in human blood are largely derived from food. In addition to the food origin of glycols, other potential sources should also be considered. Zhu et al. [14] measured airborne EG and PG in nonoccupational environments, and found that EG and PG concentrations in a residential indoor air sample were 53 and 13 lg/m 3 , respectively. If these values are accurate, it is possible that the EG and PG levels listed in Table 4 are caused by background levels in the air; these compounds are very hydrophilic and could be easily incorporated into and condensed in human blood via respiration.
Conclusions
In the present study, we have developed a highly sensitive method for analysis of EG, PG, and DEG in human whole blood by GC-MS using HFB derivatization. Due to its very high sensitivity, the glycols could also be detected in Milli-Q water and Evian mineral water. The glycol that was highest in whole blood of healthy subjects was PG, followed by EG and DEG. This is the first report of appreciable amounts of the three glycols existing in whole blood of nonoccupational healthy humans. Our results show that every aqueous item is contaminated by these glycols in highly industrialized countries. In previous studies, the three glycols had been analyzed, but only when humans had been poisoned through exposure to very high glycol concentrations. The health effects of long-term exposure to glycols at sub-toxic levels in humans remain to be explored. In addition, preexisting glycol levels in healthy subjects are very informative to set cutoff levels of the glycols in their poisoning cases. The higher the sensitivity of an analytical method the better, because very small amounts of samples can be analyzed, and/or the sample can be diluted to a great extent to give clean samples for analysis. The present highly sensitive GC-MS method is expected to be very useful for analysis of glycols in forensic and clinical toxicology.
